C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2002
08/01/2002	WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same
08/01/2002	WO2002000928A3 Diagnosis of diseases associated with the immune system by determining cytosine methylation
08/01/2002	WO2002000903A3 Esr1 - a plant gene that can promote plant regeneration and transformation
08/01/2002	WO2002000718A3 A human calcium channel protein and uses thereof
08/01/2002	WO2002000013A3 Meiotic spindle imaging in oocytes and uses therefor in in vitro fertilization
08/01/2002	WO2001098453A3 Modified construct downstream of the initiation codon for recombinant protein overexpression
08/01/2002	WO2001098367A3 Neuroactive peptides for treatment of hypoxia and related conditions
08/01/2002	WO2001096565A3 Binding agents: chimeric ligand/receptor proteins
08/01/2002	WO2001092551A3 Duplexed parvovirus vectors
08/01/2002	WO2001091799A3 Medicament for the treatment of immune reactions in the eye
08/01/2002	WO2001090318A3 Regulation of human polyamine oxidase-like enzyme
08/01/2002	WO2001090190A3 Single-domain antigen-binding antibody fragments derived from llama antibodies
08/01/2002	WO2001088169A3 Method for producing carotenoid compounds in plants
08/01/2002	WO2001087925A3 Methods for refolding proteins containing free cysteine residues
08/01/2002	WO2001083736A3 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof
08/01/2002	WO2001083554A3 Anti-inflammatory compounds and uses thereof
08/01/2002	WO2001083527A3 Glucagon antagonists
08/01/2002	WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
08/01/2002	WO2001075114A3 Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
08/01/2002	WO2001075113A3 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
08/01/2002	WO2001075110A3 Mucin-1 specific binding members and methods of use thereof
08/01/2002	WO2001072836A3 G-protein coupled receptors
08/01/2002	WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
08/01/2002	WO2001070955A3 Identification of essential genes in prokaryotes
08/01/2002	WO2001070950A3 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion
08/01/2002	WO2001062912A3 Method of modulating glycosylation pathways
08/01/2002	WO2001048239A3 Screening method for nucleic acids
08/01/2002	WO2001045492A3 Protein kinase stress-related proteins and methods of use in plants
08/01/2002	WO2001034808A9 Method of large-scale production and method of testing of the biological activity of a substance from soybean
08/01/2002	WO2001032935A9 Molecular microarrays and methods for production and use thereof
08/01/2002	WO2001029251A3 Improved mutation analysis of the nf1 gene
08/01/2002	WO2001029072A9 P15paf cell cycle proteins associated with pcna, compositions and methods of use
08/01/2002	WO2001027301A9 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
08/01/2002	WO2001026678A9 Short segments of dap-kinase
08/01/2002	WO2001026454A9 Preparation and selection of donor cells for nuclear transplantation
08/01/2002	WO2001004267A9 One-step allelic exchange in mycobacteria with conditional transducing phage
08/01/2002	WO2000077040A9 Human intracellular signaling molecules
08/01/2002	US20020104132 Methods for tissue culturing and transforming elite inbreds of Zea mays L.
08/01/2002	US20020104131 Propagating preferential corn plants; obtain corn embryos, incubate in nutrient broth, propagate recover plants
08/01/2002	US20020104130 Isolation and characterization of heat shock protein
08/01/2002	US20020104127 Genetically engineered plant cells for use in the generation of heterlogous proteins
08/01/2002	US20020104126 Production of bovine lysozyme by plant viral vectors
08/01/2002	US20020104125 Nucleotide sequences coding enzymatic polypeptide for use in transforming plants and amplifying preferential oil concentration in plants
08/01/2002	US20020104124 Method of modifying the content of cottonseed oil
08/01/2002	US20020104123 Viral amplification of recombinant messenger RNA in transgenic plants
08/01/2002	US20020104122 Generating disease resistant plants; obtain plants, transform with expression vector, propagate and monitor plants resistance to disease
08/01/2002	US20020104121 The maize A3 promoter and methods for use thereof
08/01/2002	US20020104120 Transgenic plants carrying neoxanthin cleavage enzyme gene
08/01/2002	US20020104119 Transcription regulatory sequences derived from Chlamydomonas reinhardtii
08/01/2002	US20020104118 Plant kinases and methods of modulation of their activity in plants
08/01/2002	US20020104117 Nucleotide sequence coding for use as tools in the generation of disease and herbicide resistant plants
08/01/2002	US20020104116 Generating disease resistant plants; obtain plant, transform with viral nucleotide sequences, recover transform plant, monitor for disease resistance
08/01/2002	US20020104114 Mammalian animal model for use in the evaluation and treatment of brain tumors
08/01/2002	US20020104113 Nav2 channel gene-deficient non-human animals
08/01/2002	US20020104112 Ikaros regulatory elements and uses thereof
08/01/2002	US20020104110 Immunologically privileged cells and uses thereof
08/01/2002	US20020104109 Transgenic animals
08/01/2002	US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors
08/01/2002	US20020104107 Animal model for use in developing treatment for nicotine addiction and epilepsey
08/01/2002	US20020104106 Fly model for evaluating tumor propagation
08/01/2002	US20020104104 Method for identifying alzheimer's disease therapeutics using transgenic animal models
08/01/2002	US20020103370 Water-soluble polysaccharide for use in food processing
08/01/2002	US20020103366 One pot deprotection of preferential nucleotide sequences; obtain nucleotide sequences, incubate with triethylamine at room temperature, incubate with anhydrous triethylamine hydrogen fluoride, heat, recover nucletide sequences
08/01/2002	US20020103363 Promoter derived from phytosulfokine precursor gene
08/01/2002	US20020103362 Polypeptide compositions toxic to anthonomus insects, and methods of use
08/01/2002	US20020103359 Nucleotide sequences coding polypeptide for use in treatment and diagnosis of psychologicaland eating disorders
08/01/2002	US20020103358 Nucleotide sequences coding preferential polypeptide for use in tumor therapy
08/01/2002	US20020103357 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids, medicines and human nutrients
08/01/2002	US20020103355 Purified plant expansin proteins and DNA encoding same
08/01/2002	US20020103351 32146 and 57259, novel human transporters and uses therefor
08/01/2002	US20020103349 Drug-oligonucleotides chimeric molecules
08/01/2002	US20020103346 Reptile venom polypeptide for use in reduction of complement activity
08/01/2002	US20020103345 Bispecific immunoglobulin-like antigen binding proteins and method of production
08/01/2002	US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
08/01/2002	US20020103342 Polypeptide for use in the diagnosis, prevention, and treatment of developmental, reproductive, immunological, and tumor disorders
08/01/2002	US20020103340 Rab proteins
08/01/2002	US20020103338 Staphylococcus aureus polynucleotides and polypeptides
08/01/2002	US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002	US20020103336 Cloning of chicken anemia dna
08/01/2002	US20020103334 Aprotinin variants having a net charge of +3 to -3 at pH 7 and with the amino acids Arg15 or Arg15-Ala17 in the binding region; serine protease inhibitor
08/01/2002	US20020103156 Administering a nucleic acid to express a gene product in cells by treating the tissue to increase vascular permeability of exogenous nucleic acid; administering exogenous nucleic acid to the tissue; low calcium ion
08/01/2002	US20020103155 Vectors for the expression of FGF-5 in human cells and uses thereof
08/01/2002	US20020103154 Identifying genes, e.g. Saccharomyces cerevisiae, essential for germination and proliferation and using the identified genes or their encoded proteins as targets for highly specific fungicides, etc.; antifungal agents,
08/01/2002	US20020103153 Antiproliferative and anticarcinogenic agents; gene therapy
08/01/2002	US20020103152 Methods of in vivo gene transfer using a sleeping beauty transposon system
08/01/2002	US20020103151 Methods and compositions for immunomodulation
08/01/2002	US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy
08/01/2002	US20020103148 Vectors comprising SAR elements
08/01/2002	US20020103147 Enhancing cardiac function in a mammal by delivering to the heart a vector comprising a gene encoding a beta-adrenergic signaling protein (beta-ASP) operably linked to a promoter; using a recombinant viral vector replication-defective
08/01/2002	US20020103146 An antisense oligonucleotide encoding the title protein specifically hybridizes with and inhibits the expression of the title protein; antiproliferative, -carcinogenic agents; viricides; hepatitis
08/01/2002	US20020103144 Retroviral gene transfer vectors
08/01/2002	US20020103143 Use of nucleic acid molecules as antiviral agents
08/01/2002	US20020103142 Protective, interactive, non-condensing compounds used to prolong localized bioavailability and enhancing expression of a nucleic acid; anticancer agents
08/01/2002	US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/01/2002	US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption
08/01/2002	US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell
08/01/2002	US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods
08/01/2002	US20020103114 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia
08/01/2002	US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease
08/01/2002	US20020103104 Administering to individual a antibacterially effective amount of an antagonist that inhibits or an agonist that activates an activity of a signal recognition particle polypeptide

1 ... 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 ... 4023